<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04921774</url>
  </required_header>
  <id_info>
    <org_study_id>81771799</org_study_id>
    <nct_id>NCT04921774</nct_id>
  </id_info>
  <brief_title>Research on Patients With Heart Transplantation</brief_title>
  <official_title>Research on the Pathogenesis and Early Diagnosis of Acute Rejection in Patients With Heart Transplantation by Using Multimodality MR Imaging Combined With Circulating Exosomal miRNA Expression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Provincial People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial was a single-center, prospective cohort study.The purpose of this clinical&#xD;
      research is to evaluate the accuracy of combining multimodality MR Imaging with circulating&#xD;
      exosomal miRNA expression to diagnose acute rejection in patients with heart&#xD;
      transplantationï¼Œthus it may be helpful for timely intervention to improve the patient's&#xD;
      prognosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute rejection (AR) after heart transplantation remains the major factor limiting long-term&#xD;
      survival, and an independent risk factor for chronic allograft vasculopathy. Currently, there&#xD;
      remains no reliable non-invasive method to detect AR. Multimodality magnetic resonance (MR)&#xD;
      imaging shows accurate detection of myocardial damage, such as interstitial cell infiltrates,&#xD;
      edema, hemorrhage, myocyte damage/necrosis and capillary stenosis or fragmentation. It turned&#xD;
      out that the indicators in both MR imaging and circulating exosomal miRNA showed difference&#xD;
      between patients with and without AR in our initial research work. Therefore, we hypothesize&#xD;
      that circulating exosomal miRNA may play an important role in the activation of signaling&#xD;
      pathway in AR after heart transplantation, which can be detected by multimodality MR imaging.&#xD;
      All transplant recipients receiving transplantation follow-up care in our center were&#xD;
      approached. In the present research we aim to combine multimodality MR imaging with&#xD;
      circulating exosomal miRNA to explore a new evaluation methodology and platform for early and&#xD;
      noninvasive detection of AR after heart transplantation. We attempt to confirm contribution&#xD;
      of circulating exosomal miRNA to myocardial damage of AR through biopsy-proven allograft&#xD;
      rejection and animal heterotopic heart transplantation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of combining multimodality MR Imaging with circulating exosomal miRNA expression in evaluating acute rejection in patients with heart transplantation.</measure>
    <time_frame>At 6 months after surgery</time_frame>
    <description>defined as the model's capability of accurately identifying patients who will have acute rejection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specificity of combining multimodality MR Imaging with circulating exosomal miRNA expression in evaluating acute rejection in patients with heart transplantation.</measure>
    <time_frame>At 6 months after surgery</time_frame>
    <description>defined as the model's capability of accurately identifying patients who will not have acute rejection.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Transplant Rejection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients after orthotopic heart transplantation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. All patients after orthotopic heart transplantation.&#xD;
&#xD;
          2. All patients has signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with early graft failure within 24-48h after transplantation requiring&#xD;
             clinical support or intensive care treatment.&#xD;
&#xD;
          2. Patients with severe renal failure.&#xD;
&#xD;
          3. Patients with any general contraindication to MRI.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hui Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Provincial People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hui Liu, MD</last_name>
    <phone>+86 13580352002</phone>
    <email>liuhuijiujiu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tingyu Li</last_name>
    <phone>+8613825060605</phone>
    <email>892460090@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>5100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hui Liu, MD</last_name>
      <phone>+8613590352002</phone>
      <email>liuhuijiujiu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong Provincial People's Hospital</investigator_affiliation>
    <investigator_full_name>Hui Liu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Multimodality</keyword>
  <keyword>Heart Transplantation</keyword>
  <keyword>Exosome</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

